Akari Therapeutics (AKTX) said Thursday that it has appointed Abizer Gaslightwala as president and chief executive officer, starting April 21.
Gaslightwala was most recently senior vice president and franchise head for US Oncology at Jazz Pharmaceuticals (JAZZ), Akari said.
Gaslightwala was appointed to Akari's board in December, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.